Will Amgen say “Patent” 2+ times?

Amgen did not say “Patent” on its Nov 3, 2026 call (FY26 Q3); it said it 2+ times on 1 of its last 8 calls: 1, 0, 0, 1, 0, 3, 1, 0 times. As of Nov 11, 2026, Amgen did not say “Patent” 2+ times on the only call with a settled Kalshi mention market so far, on Nov 3, 2026. Parrot’s p for the next listing is 19% (n=1, from settlement history blended with transcripts), not a forecast.

19%from settlement history blended with transcripts · n=1Next: Earnings call, Feb 2, 2027 · counts: company speakers + operator
Last 10
0/1Last 10 settled, oldest to newest: no
Streak
not said last time
Counts
company speakers + operator
Market
18¢ Kalshi (may be delayed)
Updated

Where it was said

quotes of at most 25 words; select an appearance

Amgen

Patent (2+ times)

Probability
19% · n=1
Settled
0/1 (0%)
Last calls
said in 1 of 8

Next listing counts: company speakers + operator

FY26 Q3 earnings call, Nov 3, 2026 · not said

Open the appearance

FY26 Q2 earnings call, Aug 4, 2026 · said 1 time (below the threshold)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

1 counted (1 in prepared remarks, 0 in Q&A).

Bob BradwaycompanypreparedIn transcript

…depth of our portfolio, once again demonstrate our ability to grow through patent expirations and increased competition. We're pleased with the momentum across our business,…

FY26 Q1 earnings call, Apr 30, 2026 · said 3 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

3 counted (3 in prepared remarks, 0 in Q&A).

Robert BradwaycompanypreparedIn transcript

…we expect our rapidly growing products to offset the financial impact of patent expirations and increased competition, while our next generation of molecules progress through…

Robert BradwaycompanypreparedIn transcript

…once again to demonstrate that we can grow through a period of patent expiration and deliver attractive performance for our shareholders with a strong portfolio…

Every match in the transcript

FY25 Q4 earnings call, Feb 3, 2026 · not said

Open the appearance

FY25 Q3 earnings call, Nov 4, 2025 · said 1 time (below the threshold)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

1 counted (0 in prepared remarks, 1 in Q&A).

Robert BradwaycompanyqaIn transcript

…with patients having access to alternative supplies of important medicines after their patents have expired. And we would watch carefully to make sure that policies…

FY25 Q2 earnings call, Aug 5, 2025 · not said

Open the appearance

FY25 Q1 earnings call, May 1, 2025 · not said

Open the appearance

FY24 Q4 earnings call, Feb 4, 2025 · said 1 time (below the threshold)

Open the appearance

Every settled listing

newest first · 1 shown
Every settled listing of this word, newest first
DateListed asVenueResultOur count
Nov 3, 2026Patent (2+ times)KalshiNo0

Questions

How many times did Amgen say “Patent” on its last earnings call?
Amgen did not say “Patent” on its Nov 3, 2026 call (FY26 Q3); it said it 2+ times on 1 of its last 8 calls: 1, 0, 0, 1, 0, 3, 1, 0 times.
How often does Amgen say “Patent (2+ times)”?
As of Nov 11, 2026, Amgen did not say “Patent” 2+ times on the only call with a settled Kalshi mention market so far, on Nov 3, 2026.
What is the probability Amgen says “Patent (2+ times)” next time?
19%, from settlement history blended with transcripts (n=1). It is a base rate from history, not a forecast and not advice.
Who has to say it for the market to count?
Under the next market's rule: company speakers + operator.

Cite parrot.markets, “Amgen: ‘Patent (2+ times)’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/patent-2plus (CC BY 4.0)

Agents: this page as TSV at /api/v1/word?entity=amgen&word=patent%20%282%2B%20times%29 · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP